1 year return (CAGR)
-30.97%
Grace Therapeutics, Inc. Exchange (NASDAQ, USD)
GRCE
2.14
+0.04 (+1.90%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
2.11%
5 year return (CAGR)
-30.50%
10 year return (CAGR)
-28.74%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
45.02M
Price/Sales
-
Ent value
33.12M
Price/Book
0.93
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-43.17%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.10 |
| Daily high | 2.17 |
| Daily low | 2.09 |
| Daily Volume | 70K |
| All-time high | 1953.60 |
| 1y analyst estimate | 6.05 |
| Beta | 0.43 |
| EPS (TTM) | -1.24 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GRCE | S&P500 | |
| Current price drop from All-time high | -99.89% | -0.58% |
| Highest price drop | -99.91% | -56.47% |
| Date of highest drop | 22 Sep 2023 | 9 Mar 2009 |
| Avg drop from high | -85.88% | -10.68% |
| Avg time to new high | 50 days | 12 days |
| Max time to new high | 3303 days | 1805 days |
News
